X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.prnewswire.com/news-releases/viatris-announces-launch-of-breyna-budesonide-and-formoterol-fumarate-dihydrate-inhalation-aerosol-the-first-fda-approved-generic-version-of-symbicort-for-people-with-asthma-and-chronic-obstructive-pulmonary-disease-in-partn-301888925.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215621
https://www.indianpharmapost.com/news/briefs-lupin-and-gmm-pfaudler-13364
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216486
https://health.economictimes.indiatimes.com/news/pharma/lupin-gets-usfda-nod-for-formoterol-fumarate-inhalation-solution/93756279
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215053
http://www.pharmafile.com/news/730650/nhs-scotland-recommends-chiesi-s-trimbow-asthma
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211699
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215078
https://www.fiercepharma.com/pharma/astrazeneca-chalks-up-double-win-for-novel-combo-asthma-rescue-inhaler
http://www.pharmafile.com/news/566249/european-approval-astrazenecas-trixeo-aerospace-moderate-severe-copd
http://www.pharmatimes.com/news/eu_for_az_copd_maintenance_therapy_1359973
https://www.astrazeneca.com/media-centre/press-releases/2020/new-analyses-from-breztri-aerosphere-phase-iii-ethos-trial-to-be-presented-at-the-european-respiratory-society-international-congress-2020.html
https://www.raps.org/news-and-articles/news-articles/2020/7/fda-approvals-roundup-tecartus-breztri-aerosphere
https://www.astrazeneca.com/media-centre/press-releases/2020/breztri-aerosphere-significantly-reduced-rate-of-moderate-or-severe-copd-exacerbations-in-phase-iii-ethos-trial.html
https://www.astrazeneca.com/media-centre/press-releases/2020/bevespi-aerosphere-approved-in-china-for-patients-with-copd.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213068
https://www.ema.europa.eu/en/documents/overview/budesonide/formoterol-teva-pharma-bv-epar-medicine-overview_en.pdf
https://www.biospace.com/article/releases/circassia-pharmaceuticals-launches-duaklir-pressair-aclidinium-formoterol-for-patients-with-chronic-obstructive-pulmonary-disease-copd-/?s=95
https://www.fiercepharma.com/marketing/fda-stonewalls-astrazeneca-s-copd-triplet-breztri-handing-gsk-s-trelegy-a-reprieve
https://www.fiercepharma.com/pharma-asia/foreign-drugmakers-under-threat-as-china-rolls-out-drug-list-to-boost-generic
https://www.fiercepharma.com/pharma/astrazeneca-s-copd-triplet-breztri-rival-to-gsk-s-trelegy-nabs-first-nod-from-japan
http://www.pharmatimes.com/news/az_symbicort_reduces_rate_of_asthma_attacks_1288768
https://www.fiercepharma.com/pharma/as-astrazeneca-returns-to-growth-ceo-soriot-lays-out-new-plan-led-by-cancer-drugs
https://www.businesswire.com/news/home/20190417005363/en/Food-Drug-Administration-Approves-DUAKLIR%C2%AE-PRESSAIR%C2%AE-aclidiniumformoterol/?feedref=JjAwJuNHiystnCoBq_hl-QyNsUQ29c24MKpwrFSKUOTZQK86VRF04E6aMvZHPoaH7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LP6oD-t3eB0qV-nJQ-WeFyCEq7XOd8em_Uy42DWNTo2Mw==
https://www.ema.europa.eu/documents/product-information/bevespi-aerosphere-epar-product-information_en.pdf
http://www.pharmatimes.com/news/ema_approves_flutiform_for_children_with_asthma_1274699
https://endpts.com/astrazenecas-respiratory-team-acknowledges-its-latest-setback-trial-flops/
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-15-18-october-2018
http://www.pmlive.com/pharma_news/az_prepares_to_file_copd_triple,_taking_on_rival_gsk_1252574
https://markets.businessinsider.com/news/stocks/astrazeneca-kronos-phase-iii-trial-met-eight-of-nine-primary-endpoints-1027538490
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-symbicort-21929-budesonide-and-formoterol-fumarate-dihydrate-metered-inhalation-1535780014.pdf
http://www.pmlive.com/pharma_news/az_rival_to_gsks_copd_drug_anoro_fails_head-to-head_test_1249945
https://endpts.com/hit-by-surprise-setback-astrazeneca-scrambles-to-explain-why-its-two-in-one-copd-inhaler-fails-to-beat-gsk-rival/
https://www.reuters.com/article/us-astrazeneca-lung/astrazeneca-inhaler-lags-gsk-drug-in-lung-disease-trial-idUSKCN1L80L3
https://www.pharmacompass.com/pdf/news/chiesi-farmaceuticis-riarify-beclometasone-formoterol-glycopyrronium-bromide-receives-approval-in-europe-1524809608.pdf
https://www.raps.org/news-and-articles/news-articles/2018/2/ema%E2%80%99s-chmp-recommends-five-new-medicines-for-appro?utm_source=Email&utm_medium=Informz&utm_campaign=Informz-Emails&_zs=VHOsL1&_zl=k7BK4
http://www.pharmatimes.com/news/five_new_medicines_backed_for_eu_approval_1223972
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/02/news_detail_002907.jsp&mid=WC0b01ac058004d5c1
https://www.fiercepharma.com/pharma/busy-az-posts-q4-beats-as-execs-promise-light-at-end-tunnel
http://www.fiercepharma.com/pharma/astrazeneca-s-latest-respiratory-win-could-spur-bevespi-approvals-china-japan
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207306
https://www.pharmacompass.com/pdf/news/chiesi-farmaceuticis-trimbow-beclometasone-formoterol-glycopyrronium-bromide-receives-approval-in-europe-1502451025.pdf
http://www.pharmatimes.com/news/eu_nod_for_chiesis_copd_therapy_1199305
http://www.businesswire.com/news/home/20170605006175/en/Flex-Pharma-Announces-Executive-Leadership-Transition
http://raps.org/Regulatory-Focus/News/2017/05/19/27614/EMA%E2%80%99s-CHMP-Recommends-Approval-for-Five-New-Medicines-Four-New-Biosimilars/?utm_source=Email&utm_medium=Informz&utm_campaign=Informz-Emails
Market Place
Share 
